Home/ Stocks/ HOWL

Werewolf Therapeutics, Inc. Common Stock

HOWL XNAS

$0.68 +0.06 (+10.02%) ▲ 15-min delayed

Open

$0.62

High

$0.78

Low

$0.61

Volume

2.43M

Market Cap

$33.05M

About Werewolf Therapeutics, Inc. Common Stock

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 39 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-60,822,000	$-1.32
FY 2025	$0	$-60,822,000	$-1.32
Q3 2025	$0	$-16,370,000	$-0.36
Q2 2025	$0	$-17,982,000	$-0.40

Related Market News

No specific coverage for HOWL yet. Check out our latest market news or earnings calendar.

Get HOWL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Werewolf Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.